Identification and Management of Acute Neuromuscular Respiratory Failure in the ICU.
Guillain-Barré syndrome
ICU-acquired weakness
amyotrophic lateral sclerosis
myasthenia gravis
neuromuscular respiratory failure
Journal
Chest
ISSN: 1931-3543
Titre abrégé: Chest
Pays: United States
ID NLM: 0231335
Informations de publication
Date de publication:
Dec 2023
Dec 2023
Historique:
received:
31
05
2023
revised:
22
08
2023
accepted:
12
09
2023
medline:
10
12
2023
pubmed:
10
12
2023
entrez:
9
12
2023
Statut:
ppublish
Résumé
Respiratory failure is a common and potentially life-threatening complication of neuromuscular diseases. Prompt recognition and accurate diagnosis of new or worsening chronic neuromuscular disease have important clinical management and prognostic implications. In this article, we present an approach to the acute presentation of undifferentiated neuromuscular respiratory failure in the ICU and guidance for determination and respiratory management of the underlying disorder.
Identifiants
pubmed: 38070961
pii: S0012-3692(23)05433-8
doi: 10.1016/j.chest.2023.09.009
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1454-1461Informations de copyright
Copyright © 2023. Published by Elsevier Inc.
Déclaration de conflit d'intérêts
Financial/Nonfinancial Disclosures The authors have reported to CHEST the following: J. B. C. has a grant from Catalyst Pharmaceuticals Inc and receives clinical trial support from MTB Pharma Inc and Amylyx Pharmaceuticals. The institution receives funding on behalf of D. C. F. from NIH, CDC, and Quantum Leap Healthcare Collaborative. D. C. F. has worked as a consultant for Cytovale and Medpace. None declared (J. T. W. K., A. C.).